🔗 Share this article TikTok Influencers Driving Unofficial Trade for Unlicensed Slimming Medication An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations. Experimental Drug Gaining Traction Online The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are urged to message these profiles privately for supplier links, while also receiving discount codes. Thriving Commerce on Messaging Platforms Separately, a flourishing trade exists on messaging services, where communities with numerous of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Sellers market the drug there before redirecting customers to WhatsApp for purchases. Learning About The Experimental Drug Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic. Medical Professionals Voice Concerns Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could result in users administering products of unknown origin. Some experts stated the demand for the experimental drug could be connected to the rising cost of licensed slimming products such as Mounjaro. Regulatory Status and Enforcement Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the British medical regulations. Several influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and customer laws, risking penalties, legal action or imprisonment. Service Reaction and Material Elimination Based on the social media company, the platform has removed violative content and banned related keywords and query recommendations. The organization said it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies. Digital Trading Operations Research also found communities with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays groups with numerous of users, filled with images of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at residence. Within minutes of entering one group, a seller shared WhatsApp details, where the majority of transactions take place. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, medical conditions or past usage. Item Information and Costs Within these communities, posts show black plastic parcels with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.” Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled pens typically priced at £160 for 20mg. When questioned how long a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”. Platform Oversight and Safety Measures A spokesperson for the messaging service stated it actively moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”. Medical Expert Cautions “Individuals are administering materials they can’t verify. Even if the science behind this drug is valid, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U. A medical professional of an online medical service connected the surge in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said. Her staff has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.” Manufacturer Statement A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to possibly serious health risks”.